LONZA GROUP AG UNSP ADR EACH RE (LZAGY) Financials
LZAGY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-06-30 | 19.7 billion | 8.1 billion |
2022-12-31 | 18.8 billion | 7.2 billion |
2022-09-30 | ? | ? |
LZAGY Free Cash Flow and Stock based compensation
No data available :(
LZAGY Net Income
Date | Net Income |
---|---|
2023-12-31 | 145.1 million |
2023-06-30 | 228.0 million |
2022-12-31 | 391.0 million |
2022-09-30 | 370.7 million |
LZAGY Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-06-30 | 2.4 billion | - | - |
2022-12-31 | 2.4 billion | - | 384.0 million |
2022-09-30 | - | - | - |
LZAGY Shares Outstanding
LZAGY Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-06-30 | - | - | - | - |
2022-12-31 | 532.7 million | - | - | - |
2022-09-30 | 505.0 million | - | - | - |
LZAGY Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-06-30 | - | - |
2022-12-31 | - | - |
2022-09-30 | - | - |
LZAGY
Price: $57.41
Dividend Yield: 0.07%
Forward Dividend Yield: 0.66%
Payout Ratio: 38.97%
Dividend Per Share: 0.38 USD
Earnings Per Share: 0.97 USD
P/E Ratio: 30.13
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 52072
Ebitda: 1.0 billionMarket Capitalization: 42.4 billion
Average Dividend Frequency: 1
Years Paying Dividends: 15
DGR3: 30.00%
DGR5: 18.13%
DGR10: 30.00%